Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
EMP16-02 120 mg orlistat/40 mg acarbose
DRUG
2 trials
Sponsors
Empros Pharma AB
Conditions
Obesity and Overweight
Overweight or Obese
Overweight or Obesity
Phase 1
A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)
Completed
NCT04521751
Empros Pharma AB
Overweight or Obesity
Start: 2020-05-07
End: 2021-08-30
Updated: 2022-04-04
Phase 2
A Trial With EMP16 in Preparation for Late Phase Studies
Not yet recruiting
NCT06993428
Empros Pharma AB
Obesity and Overweight, Overweight or Obese
Start: 2025-05-20
End: 2025-07-29
Target: 39
Updated: 2025-05-28